Cholecystokinin-2 receptors couple to cAMP-protein kinase A to depress excitatory synaptic currents in rat nucleus accumbens in vitro

Canadian Journal of Physiology and Pharmacology

Volumn 84, Issue 2, 2006, Pages 203-211

  Kombian, Samuel B ^a   Ananthalakshmi, Kethireddy V V ^a   Parvathy, Subramanian S ^a   Matowe, Wandikayi C ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Adenylyl cyclase; Cholecystokinin; GABAB receptors; Neuropeptides; Second messengers; Synaptic modulation

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 8 BROMO CYCLIC AMP; ADENYLATE CYCLASE; BACLOFEN; BENZYL[3 [[1 (3,4 DICHLOROPHENYL)ETHYL]AMINO] 2 HYDROXYPROPYL]PHOSPHINIC ACID; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE; CYCLIC AMP DERIVATIVE; FORSKOLIN; G PROTEIN COUPLED RECEPTOR; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; ROLIPRAM;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; EXCITATORY POSTSYNAPTIC POTENTIAL; FOREBRAIN; IN VITRO STUDY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; EXCITATORY POSTSYNAPTIC POTENTIALS; MALE; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CHOLECYSTOKININ B; SIGNAL TRANSDUCTION; SINCALIDE;

EID: 33745145847     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y05-119     Document Type: Article

References (44)

1. Banke, T.G., Bowie, D., Lee, H., Huganir, R.L., Schousboe, A., and Traynelis, S.F. 2000. Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase. J. Neurosci. 20: 89-102. PMID: 10627585.
2. Beinfeld, M.C. 2003. What we know and what we need to know about the role of endogenous CHOLECYSTOKININ in psychostimulant sensitization. Life Sci. 73: 643-654. doi: 10.1016/80024-3205(03)00384-9. PMID: 12801586.
3. Beinfeld, M.C., and Garver, D.L. 1991. Concentration of cholecystokinin in cerebrospinal fluid is decreased in psychosis: relationship to symptoms and drug response. Prog. Neuropsychopharmacol. Biol. Psychiatry, 15: 601-609. doi: 10.1016/0278-5846(91) 90050-B. PMID: 1956989.
4. Bowery, N.G., Hill, D.R., Hudson, A.L., Doble, A., Middlemiss, D.N., Shaw, J., and Turnbull, M. 1980. (-)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor. Nature, 283: 92-94. doi: 10.1038/283092a0. PMID: 6243177.
5. Branchereau, P., Champagnat, J., and Denavit-Saubie, M. 1993. Cholecystokinin-gated currents in neurons of the rat solitary complex in vitro. J. Neurophysiol. 70: 2584-2595. PMID: 7509860.
6. Brog, J.S., Salyapongse, A., Deutch, A.Y., and Zahm, D.S. 1993. The patterns of afferent innervation of the core and shell in the "accumbens" part of the rat ventral striatum: immunohistochemical detection of retrogradely transported fluro-gold. J. Comp. Neurol. 338: 255-278. doi: 10.1002/cne.903380209. PMID: 8308171.
7. Carlberg, M., Gundlach, A.L., Mercer, L.D., and Beart, P.M. 1992. Autoradiographic localization of cholecystokinin A and B receptors in rat brain using [125I]d-Tyr25(Nle28,31)-CCK 25-33. Eur. J. Neurosci. 4: 563-573. PMID: 12106342.
8. B-related G protein coupled receptor. Brain Res. Mol. Brain Res. 110: 305-317. PMID: 12591167.
9. Chavez-Noriega, L.E., and Stevens, C.F. 1992. Modulation of synaptic efficacy in field CA1 of the rat hippocampus by forskolin. Brain Res. 574: 85-92. doi: 10.1016/0006-8993(92)90803-H. PMID: 1379110.
10. Chijiwa, T., Mishima, A., Hagiwara, M., Sano, M., Hayashi, K., Inoue, K., et al. 1990. Inhibition of forskolin-induced neunte outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5- isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265: 5267-5272. PMID: 2156866.
11. Crawley, J.N., and Corwin, R.L. 1994. Biological actions of cholecystokinin. Peptides, 15: 731-755. doi: 10.1016/0196-9781(94) 90104-X. PMID: 7937354.
12. Crespi, F. 1998. The role of cholecystokinin, cholecystokinin-A or cholecystokinin-B receptor antagonists in the spontaneous preference for drugs of abuse (alcohol or cocaine) in naive rats. Methods Find. Exp. Clin. Pharmacol. 20: 679-697. doi: 10. 1358/mf.1998.20.8.487502. PMID: 9922984.
13. B receptors in the CA1 region of rat hippocampus. Neuropharmacology, 32: 1071-1073. doi: 10.1016/0028-3908(93)90073- C. PMID: 8295715.
14. Detjen, K., Yule, D., Tseng, M.-J., Williams, J.A., and Logsdon, C.D. 1997. Cholecystokinin-B receptors produce similar signals but have opposite growth effecst in CHO and Swiss 3T3 cells. Am. J. Physiol. 273: C1449-C1457. PMID: 9374628.
15. Ferraro, L., O'Connor, W.T., Li, X.M., Rimondini, R., Beani, L., Ungerstedt, U., Fuxe, K., and Tanganelli, S. 1996. Evidence for a differential cholecystokinin-B and -A receptor regulation of GABA release in the rat nucleus accumbens mediated via dopaminergic and cholinergic mechanisms. Neuroscience, 73: 941-950. doi: 10.1016/0306-4522(96)00098-X. PMID: 8809813.
16. Frere, S.G., and Luthi, A. 2004. Pacemaker channels in mouse thalamocortical neurones are regulated by distinct pathways of cAMP synthesis. J. Physiol. 554: 111-125. PMID: 14678496.
17. Geilen, C.C., Wieprecht, M., Wieder, T., and Reutter, W. 1992. A selective inhibitor of cyclic AMP-dependent protein kinase, N-[2- bromocinnamyl(amino)ethyl]-5-isoquinolinesulfonamide (H-89), inhibits phosphatidylcholine biosynthesis in HeLa cells. FEBS Lett. 309: 381-384. doi: 10.1016/0014-5793(92)80811-T. PMID: 1516714.
18. Harvey, J., and Lacey, M.G. 1996. Endogenous and exogenous dopamine depress EPSCs in rat nucleus accumbens in vitro via D1 receptors activation. J. Physiol. 492: 143-154. PMID: 8730590.
19. Joost, H.G., Habberfield, A.D., Simpson, I.A., Laurenza, A., and Seamon, K.B. 1988. Activation of adenylate cyclase and inhibition of glucose transport in rat adiposcytes by forskolin analogues: structural determinants of distinct sites of action. Mol. Pharmacol. 33: 449-453. PMID: 3357486.
20. B receptors in rat brain slices. Neuropharmacology, 35: 703-712. doi: 10.1016/00283908(96)84642-9. PMID: 8887979.
21. B receptor binding in the rat brain. Neuroscience, 52: 73-81. doi: 10.1016/0306-4522(93) 90183-0. PMID: 8381927.
22. Kombian, S.B., Ananthalakshmi, K.V.V., Parvathy, S.S., and Matowe, W.C. 2003. Substance P depresses excitatory synaptic transmission in the nucleus accumbens through dopaminergic and purinergic mechanisms. J. Neurophysiol. 89: 728-738. PMID: 12574450.
23. B receptors to excite cells and depress EPSCs in the rat rostral nucleus accumbens in vitro. J. Physiol. 555: 71-84. PMID: 14673185.
24. B receptor transduction mechanisms, cross-talk between protein kinases A and C, in GABAergic terminals synapsing onto neurons in the rat nucleus basalis of Meynert. J. Physiol. 551: 263-276. doi: 10.1113/jphysiol.2003.046524. PMID: 12815184.
25. Kuhar, M.J., Ritz, M.C., and Boja, J.W. 1991. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14: 299-302. doi: 10.1016/0166-2236(91)90141-0. PMID: 1719677.
26. Lanca, A.J., De Cabo, C., Arifuzzaman, A.I., and Vaccarino, F.J. 1998. Cholecystokinergic innervation of nucleus accumbens subregions. Peptides, 19: 859-868. doi: 10.1016/80196-9781(98) 00032-1. PMID: 9663451.
27. Lane, R.F., Blaha, C.D., and Phillips, A.G. 1986. In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens. Brain Res. 397: 200-204. doi: 10.1016/0006-8993(86)91388-0. PMID: 3801862.
28. Lanza, M., and Makovec, F. 2000. Cholecystokinin increases GABA release in the rat anterior nucleus accumbens via cholecystokinin-B receptors located on glutamatergic interneurons. Naunyn Schmiedebergs Arch. Pharmacol. 361: 33-38. doi: 10. 1007/S002109900161. PMID: 10651144.
29. Menon-Johansson, A.S., Berrow, N., and Dolphin, A.C. 1993. G(o) transduces GABAB-receptor modulation of N-type calcium channels in cultured dorsal ganglion neurons. Pflugers Arch. 425: 335-343. doi: 10.1007/BF00374184. PMID: 8309795.
30. Mercer, L.D., Le, V.Q., Nunan, J., Jones, N.M., and Beart, P.M. 2000. Direct visualization of cholecystokinin subtype2 receptors in rat central nervous system using anti-peptide antibodies. Neurosci. Lett. 293: 167-170. doi: 10.1016/80304-3940(00)01504-4. PMID: 11036187.
31. Miller, K.K., Hoffer, A., Svoboda, K.R., and Lupica, C.R. 1997. Cholecystokinin increases GABA release by inhibiting a resting K+ conductance in hippocampal interneurons. J. Neurosci. 17: 4994-5003. PMID: 9185537.
32. B receptors couple to G proteins Go, Go* and Gil but not to Gi2. FEBS Lett. 271: 231-235. doi: 10.1016/0014-5793(90)80413-0. PMID: 2172003.
33. B receptor/adenylyl cyclase system: analysis using a reconstituted system with purified GTP-binding protein from bovine cerebral cortex. Neurochem. Int. 31: 21-25. doi: 10.1016/80197-0186(96)00138-6. PMID: 9185160.
34. B receptors: from pharmacology to molecular biology. Acta Pharmacol. Sin. 21: 111-123. PMID: 11263257.
35. Pennartz, C.M., Groenewegen, H.J., and Lopes da Silva, F.H. 1994. The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data. Prog. Neurobiol. 42: 719-761. doi: 10.1016/0301-0082(94)90025-6. PMID: 7938546.
36. Piiper, A., Gebhardt, R., Kronenberger, B., Giannini, C., Elez, R., and Zeuzem, S. 2000. Pertussis toxin inhibits cholecystokinin- and epidermal growth factor-induced mitogen-activated protein kinase activation by disinhibition of the cAMP signaling pathway and inhibition of c-Raf-1. Mol. Pharmacol. 58: 608-613. PMID: 10953055.
37. Pommier, B., Da Nascimento, S., Dumont, S., Bellier, B., Million, E., Garbay, C., Roques, B.P., and Noble, F. 1999. The cholecystokinins receptor is coupled to two effector pathways through pertussis toxin-sensitive and -insensitive G proteins. J. Neurochem. 73: 281-288. doi: 10.1046/j.1471-4159. 1999.0730281.x. PMID: 10386981.
38. Pommier, B., Marie-Claire, C., Da Nascimento, S., Wang, H.L., Roques, B.P., and Noble, F. 2003. Further evidence that the CCK2 receptor is coupled to two transduction pathways using site-directed mutagenesis. J. Neurochem. 85: 454-461. PMID: 12675921.
39. B2 receptor protein in the cerebral cortex and thalamus of adult rats. Neuroreport, 12: 591-595. PMID: 11234770.
40. Rotzinger, S., and Vaccarino, F.J. 2003. Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models. J. Psychiatry Neurosci. 28: 171-181. PMID: 12790157.
41. B receptors. J. Neurosci. 18: 3138-3146. PMID: 9547222.
42. Vickroy, T.W., and Bianchi, B.R. 1989. Pharmacological and mechanistic studies of cholecystokinin-facilitated [3H]dopamine efflux from rat nucleus accumbens. Neuropeptides, 13: 43-50. PMID: 2466220.
43. Wank, S.A. 1998. G protein-coupled receptors in the gastrointestinal physiology. I. CHOLECYSTOKININ receptors: an exemplary family. Am. J. Physiol. 274: G607-G613. PMID: 9575840.
44. Wei, J.Y., Roy, D.S., Leconte, L., and Barnstable, C.J. 1998. Molecular and pharmacological analysis of cyclic nucleotide-gated channel function in the central nervous system. Prog. Neurobiol. 56: 37-64. doi: 10.1016/S0301-0082(98) 00029-X. PMID: 9723130.